Skip to main content
. 2014 Apr 8;14:191. doi: 10.1186/1471-2334-14-191

Table 4.

Supportive treatment, imaging and humoral examinations in critical patients with HFRS

  Survivors (n = 46) Non-survivors (n = 29) P value a
Supportive treatment
 
 
 
RRT, n (%)
42 (91.3)
22 (75.9)
.132
CRRT, n (%)
28 (60.9)
22 (75.9)
.180
MV, n (%)
15 (32.6)
7 (24.1)
.433
Image manifestations
 
 
 
Pulmonary effusion, n (%)
31 (62.4)
17 (58.6)
.441
Pleural effusion, n (%)
28 (60.9)
11 (37.9)
.053
Seroperitoneum, n (%)
28 (60.9)
13 (44.8)
.174
T-wave change, n (%)
6 (13)
3 (10.3)
1.000
Premature ventricular contraction, n (%)
5 (10.9)
1 (3.4)
.474
Atrial premature beats, n (%)
3 (6.5)
4 (13.8)
.518
Atrial fibrillation, n (%)
5 (10.9)
3 (10.3)
1.000
Pericardial effusion, n (%)
13 (28.3)
3 (10.3)
.065
Gallbladder swelling, n (%)
10 (21.7)
6 (20.7)
.914
Humoral examinations
 
 
 
Urine protein +++ ~ ++++, n (%)
33 (71.7)
22 (75.9)
.694
Urine occult blood +++ ~ ++++, n (%) 34 (73.9) 17 (58.6) .167

Abbreviations: RRT, renal replacement therapy; CRRT, continuous renal replacement therapy; MV, mechanical ventilation.

aSurvivors vs. non-survivors.